Skip to search formSkip to main contentSkip to account menu

Viramune

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Ammassari, A., Antinori, A., Cozzi-Lepri, A., Trotta, M.P., Nasti, G., Ridolfo, A.L., et.al., 2002. Relationship between HAART… 
2010
2010
In 2007-2008, the Perm Territorial Center for Prevention and Control of AIDS and Communicable Diseases investigated the efficacy… 
2005
2000
2000
Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is no longer widely used in the United States, mainly… 
2000
2000
A recent letter to doctors strengthened the U.S. warnings and precautions on using this antiretroviral (which has been approved… 
1999
1999
La nevirapine est le premier representant d'une nouvelle classe therapeutique (les inhibiteurs non nucleosidiques de la… 
Review
1999
Review
1999
Nevirapine is the first member of a new therapeutic class (NNRTI: non nucleoside inhibitors of the reverse transcriptase) in the… 
1998
1998
Viramune (Nevirapine) is the first non-nucleoside analog approved by the FDA for children. The suspension is administered…